HCW Biologics Inc (HCWB)
1.12
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
HCW Biologics 1 Year Total Returns (Daily): -46.28% for June 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 14, 2024 | -46.28% |
| June 13, 2024 | -44.43% |
| June 12, 2024 | -46.45% |
| June 11, 2024 | -47.03% |
| June 10, 2024 | -50.00% |
| June 07, 2024 | -50.17% |
| June 06, 2024 | -43.78% |
| June 05, 2024 | -38.81% |
| June 04, 2024 | -33.54% |
| June 03, 2024 | -31.01% |
| May 31, 2024 | -24.83% |
| May 30, 2024 | -26.85% |
| May 29, 2024 | -33.33% |
| May 28, 2024 | -33.33% |
| May 24, 2024 | -30.41% |
| May 23, 2024 | -30.38% |
| May 22, 2024 | -30.39% |
| May 21, 2024 | -24.77% |
| May 20, 2024 | -24.48% |
| May 17, 2024 | -27.63% |
| May 16, 2024 | -25.93% |
| May 15, 2024 | -21.09% |
| May 14, 2024 | -24.34% |
| May 13, 2024 | -26.32% |
| May 10, 2024 | -26.62% |
| Date | Value |
|---|---|
| May 09, 2024 | -19.46% |
| May 08, 2024 | -18.32% |
| May 07, 2024 | -13.51% |
| May 06, 2024 | -13.51% |
| May 03, 2024 | -3.62% |
| May 02, 2024 | -8.08% |
| May 01, 2024 | -0.30% |
| April 30, 2024 | -2.01% |
| April 29, 2024 | -1.31% |
| April 26, 2024 | 3.70% |
| April 25, 2024 | 4.66% |
| April 24, 2024 | 5.98% |
| April 23, 2024 | 15.76% |
| April 22, 2024 | 17.66% |
| April 19, 2024 | 4.79% |
| April 18, 2024 | 11.41% |
| April 17, 2024 | 8.16% |
| April 16, 2024 | 5.67% |
| April 15, 2024 | 8.00% |
| April 12, 2024 | 15.86% |
| April 11, 2024 | 1.99% |
| April 10, 2024 | 5.12% |
| April 09, 2024 | 14.29% |
| April 08, 2024 | 14.36% |
| April 05, 2024 | 10.41% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-63.02%
Minimum
Jul 20 2022
51.79%
Maximum
Mar 20 2024
-24.32%
Average
-23.62%
Median
1 Year Total Returns (Daily) Benchmarks
| CEL-SCI Corp | -46.28% |
| AIM ImmunoTech Inc | -1.73% |
| IGC Pharma Inc | 39.13% |
| NovaBay Pharmaceuticals Inc | -89.69% |
| Protalix BioTherapeutics Inc | -50.22% |